H. Joachim Deeg
Abstract
Open-access reader
Eltrombopag has activity in treating aplastic anemia. The role of eltrombopag in first‐line therapy for aplastic anemia should be determined in a randomized prospective trial.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Eltrombopag has activity in treating aplastic anemia. The role of eltrombopag in first‐line therapy for aplastic anemia should be determined in a randomized prospective trial.
Key concepts: Medicine, Eltrombopag, Aplastic anemia, Randomized controlled trial, Anemia, Internal medicine, Bone marrow, Immune thrombocytopenia